Description
Disease Indications
Risk of cardiovascular events, Hypertriglyceridemia
Manufacturer
Amarin Pharma Inc
Usage
Oral
Medicine approved by
-
European Medical Agency (EMA)
-
Food and Drug Administration (FDA)
-
Health Canada
Vascepa (icosapent ethyl)
$700.00
Vascepa (icosapent ethyl) is a prescription medicine used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and as an adjunct to statin therapy to reduce the risk of of cardiovascular events.
Additional information
| Package | Capsules |
|---|
Related products
-
Adbry / Adtralza (tralokinumab-ldrm)
$1,300.00 Select options This product has multiple variants. The options may be chosen on the product page -
Nexletol (bempedoic acid)
$400.00 Select options This product has multiple variants. The options may be chosen on the product page -
Attruby (acoramidis)
$10,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Repatha (evolocumab)
Price range: $500.00 through $1,200.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.